Literature DB >> 26370551

Lack of Association Between Haptoglobin Phenotype and Cystic Fibrosis Outcomes.

Michal Shteinberg1,2,3,4, Joseph Rivlin5, Michal Gur5, Muriel Konopnicki5, Nili Stein5, Michael M Tunney6, J Stuart Elborn6, Damian G Downey6, Elinor Johnston6, Hadar Shalom7, Andrew Levy7.   

Abstract

Haptoglobin (Hp), a heme-Iron chelator, has different isoforms which are associated with variable tendency toward infections: Hp 1-1, Hp 2-1, and Hp 2-2. Cystic fibrosis (CF) outcomes are variable and influenced by genetic and environmental factors. The aim of this study was to determine whether Hp phenotype influenced disease severity in CF. One hundred forty-two CF patients from two centers were analyzed for Haptoglobin phenotype using gel electrophoresis of hemoglobin enriched serum. Clinical and microbiological data including bacterial colonization status, lung function, presence of CF-related diabetes and liver disease, rate of exacerbation, and mortality were compared between Hp phenotype groups. We found a trend toward less mucoid PA among Hp 2-2 (20.4 %) compared with Hp 1-1 and Hp 2-1 individuals (33.3 %), p = 0.317. Hp 2-2 individuals also had less antibiotic courses, and lower inflammatory markers without statistical significance. Haptoglobin phenotype is unlikely to be an important modifier of CF phenotype.

Entities:  

Keywords:  Cystic fibrosis; Haptoglobin; Phenotypes

Mesh:

Substances:

Year:  2015        PMID: 26370551     DOI: 10.1007/s00408-015-9801-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  19 in total

1.  Haptoglobin 1-1 genotype and the risk of life-threatening Streptococcus infection: evolutionary implications.

Authors:  Oshri Wasserzug; Shany Blum; Eyal Klement; Flavio Lejbkowicz; Rachel Miller-Lotan; Andrew P Levy
Journal:  J Infect       Date:  2006-06-30       Impact factor: 6.072

2.  Effect of haptoglobin phenotypes on growth of Streptococcus pyogenes.

Authors:  J Delanghe; M Langlois; J Ouyang; G Claeys; M De Buyzere; B Wuyts
Journal:  Clin Chem Lab Med       Date:  1998-09       Impact factor: 3.694

Review 3.  Lung disease modifier genes in cystic fibrosis.

Authors:  Loic Guillot; Julie Beucher; Olivier Tabary; Philippe Le Rouzic; Annick Clement; Harriet Corvol
Journal:  Int J Biochem Cell Biol       Date:  2014-02-22       Impact factor: 5.085

4.  Identification of the haemoglobin scavenger receptor.

Authors:  M Kristiansen; J H Graversen; C Jacobsen; O Sonne; H J Hoffman; S K Law; S K Moestrup
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

5.  Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease.

Authors:  Edward F McKone; Jing Shao; Daisy D Frangolias; Cassie L Keener; Cynthia A Shephard; Federico M Farin; Mark R Tonelli; Peter D Pare; Andrew J Sandford; Moira L Aitken; Terrance J Kavanagh
Journal:  Am J Respir Crit Care Med       Date:  2006-05-11       Impact factor: 21.405

6.  Lactoferrin decreases inflammatory response by cystic fibrosis bronchial cells invaded with Burkholderia cenocepacia iron-modulated biofilm.

Authors:  P Valenti; A Catizone; F Pantanella; A Frioni; T Natalizi; M Tendini; F Berlutti
Journal:  Int J Immunopathol Pharmacol       Date:  2011 Oct-Dec       Impact factor: 3.219

7.  The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability.

Authors:  Sophie Moreau-Marquis; Jennifer M Bomberger; Gregory G Anderson; Agnieszka Swiatecka-Urban; Siying Ye; George A O'Toole; Bruce A Stanton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-03-21       Impact factor: 5.464

8.  Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions.

Authors:  Che Y O'May; Kevin Sanderson; Louise F Roddam; Sylvia M Kirov; David W Reid
Journal:  J Med Microbiol       Date:  2009-06       Impact factor: 2.472

Review 9.  Haptoglobin: basic and clinical aspects.

Authors:  Andrew P Levy; Rabea Asleh; Shany Blum; Nina S Levy; Rachel Miller-Lotan; Shiri Kalet-Litman; Yefim Anbinder; Orit Lache; Farid M Nakhoul; Roy Asaf; Dan Farbstein; Mordechai Pollak; Yitzhak Z Soloveichik; Merav Strauss; Jonia Alshiek; Alina Livshits; Avery Schwartz; Hoda Awad; Kheir Jad; Hagit Goldenstein
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

10.  SapF-mediated heme-iron utilization enhances persistence and coordinates biofilm architecture of Haemophilus.

Authors:  Andrew R Vogel; Blake R Szelestey; Forrest K Raffel; Samantha W Sharpe; Rachel L Gearinger; Sheryl S Justice; Kevin M Mason
Journal:  Front Cell Infect Microbiol       Date:  2012-04-03       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.